Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Escitalopram (Lexapro) for the Treatment of TBI Depression and Other Comorbid Psychiatric Conditions

NCT01368432 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT01368432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01368432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Escitalopram (Lexapro) for the Treatment of TBI Depression and Other Comorbid Psychiatric Conditions
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2010
Completion date
March 31, 2013
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depression, other psychiatric disorders, tbi